Business Description
TDS Pharm Co Ltd
ISIN : KR7464280007
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.12 | |||||
Equity-to-Asset | 0.68 | |||||
Debt-to-Equity | 0.31 | |||||
Debt-to-EBITDA | 1.05 | |||||
Interest Coverage | 16.64 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 8.61 | |||||
Beneish M-Score | -2.45 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -66 | |||||
3-Year EBITDA Growth Rate | -62.4 | |||||
3-Year EPS without NRI Growth Rate | -56.7 | |||||
3-Year FCF Growth Rate | -66.2 | |||||
3-Year Book Growth Rate | -67.9 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 23.45 | |||||
9-Day RSI | 24.31 | |||||
14-Day RSI | 26.24 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.43 | |||||
Quick Ratio | 2.18 | |||||
Cash Ratio | 1.5 | |||||
Days Inventory | 38.43 | |||||
Days Sales Outstanding | 73.92 | |||||
Days Payable | 37.03 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -249.2 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 26.43 | |||||
Operating Margin % | 16.69 | |||||
Net Margin % | 15.6 | |||||
FCF Margin % | 10.06 | |||||
ROE % | 22.73 | |||||
ROA % | 14.55 | |||||
ROIC % | 24.69 | |||||
3-Year ROIIC % | -53.67 | |||||
ROC (Joel Greenblatt) % | 41.17 | |||||
ROCE % | 26 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 17.35 | |||||
PE Ratio without NRI | 17.35 | |||||
PS Ratio | 2.72 | |||||
PB Ratio | 3.55 | |||||
Price-to-Tangible-Book | 3.58 | |||||
Price-to-Free-Cash-Flow | 26.9 | |||||
Price-to-Operating-Cash-Flow | 24.69 | |||||
EV-to-EBIT | 15.67 | |||||
EV-to-EBITDA | 13.31 | |||||
EV-to-Revenue | 3.02 | |||||
EV-to-FCF | 30.64 | |||||
Price-to-Graham-Number | 1.66 | |||||
Price-to-Net-Current-Asset-Value | 6.04 | |||||
Price-to-Net-Cash | 19.78 | |||||
Earnings Yield (Greenblatt) % | 6.39 | |||||
FCF Yield % | 2.99 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
TDS Pharm Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 30,049.355 | ||
EPS (TTM) (â‚©) | 1101 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 26.24 | ||
14-Day ATR (â‚©) | 3803.029846 | ||
20-Day SMA (â‚©) | 24850.5 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (â‚©) | 19010 - 60700 | ||
Shares Outstanding (Mil) | 5.29 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 8 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
TDS Pharm Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
TDS Pharm Co Ltd Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
TDS Pharm Co Ltd Frequently Asked Questions
What is TDS Pharm Co Ltd(XKRX:464280)'s stock price today?
When is next earnings date of TDS Pharm Co Ltd(XKRX:464280)?
Does TDS Pharm Co Ltd(XKRX:464280) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |